Editorial
doi: 10.55563/clinexprheumatol/r3k9l6.
Epub 2020 Mar 24.
COVID-19: the new challenge for rheumatologists
Affiliations
- PMID: 32207680
- DOI: 10.55563/clinexprheumatol/r3k9l6
Item in Clipboard
Editorial
COVID-19: the new challenge for rheumatologists
Clin Exp Rheumatol.
2020 Mar-Apr.
Free article
No abstract available
Comment on
-
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342. doi: 10.55563/clinexprheumatol/xcdary. Epub 2020 Mar 22. Clin Exp Rheumatol. 2020. PMID: 32202240 Review.
-
Therapies used in rheumatology with relevance to coronavirus disease 2019.Clin Exp Rheumatol. 2020 Mar-Apr;38(2):370. doi: 10.55563/clinexprheumatol/vlncdz. Epub 2020 Mar 22. Clin Exp Rheumatol. 2020. PMID: 32202241 No abstract available.
Similar articles
-
SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to Learn from Rheumatologists.J Rheumatol. 2020 Oct 1;47(10):1588-1589. doi: 10.3899/jrheum.200657. Epub 2020 May 25. J Rheumatol. 2020. PMID: 32451352 No abstract available.
-
Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?Clin Rheumatol. 2020 Jul;39(7):2099-2100. doi: 10.1007/s10067-020-05145-w. Epub 2020 May 9. Clin Rheumatol. 2020. PMID: 32388748 Free PMC article. No abstract available.
-
Drs. Cron and Chatham reply.J Rheumatol. 2020 Oct 1;47(10):1590-1591. doi: 10.3899/jrheum.200679. Epub 2020 May 25. J Rheumatol. 2020. PMID: 32451354 No abstract available.
-
Rheumatologists and Pulmonologists at Temple University Weather the COVID-19 Storm Together.J Rheumatol. 2020 Nov 1;47(11):1723. doi: 10.3899/jrheum.200740. Epub 2020 Jun 8. J Rheumatol. 2020. PMID: 32513791 No abstract available.
-
COVID-19: the new challenge for rheumatologists. One year later.Clin Exp Rheumatol. 2021 Jan-Feb;39(1):203-213. doi: 10.55563/clinexprheumatol/si106e. Epub 2021 Feb 5. Clin Exp Rheumatol. 2021. PMID: 33555253 Review.
Cited by
-
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.Mediterr J Rheumatol. 2022 Mar 31;33(1):68-74. doi: 10.31138/mjr.33.1.68. eCollection 2022 Mar. Mediterr J Rheumatol. 2022. PMID: 35611100 Free PMC article.
-
Current Take on Systemic Sclerosis Patients' Vaccination Recommendations.Vaccines (Basel). 2021 Dec 2;9(12):1426. doi: 10.3390/vaccines9121426. Vaccines (Basel). 2021. PMID: 34960174 Free PMC article. Review.
-
Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin.Ann Allergy Asthma Immunol. 2020 Sep;125(3):349-350. doi: 10.1016/j.anai.2020.06.006. Epub 2020 Jun 4. Ann Allergy Asthma Immunol. 2020. PMID: 32505720 Free PMC article. No abstract available.
-
TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.Rheumatol Ther. 2021 Sep;8(3):1355-1370. doi: 10.1007/s40744-021-00342-8. Epub 2021 Jul 23. Rheumatol Ther. 2021. PMID: 34297311 Free PMC article.
-
Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?Int J Mol Sci. 2022 Nov 12;23(22):13951. doi: 10.3390/ijms232213951. Int J Mol Sci. 2022. PMID: 36430430 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
